The International Network for Translating Research
on Perinatal Derivatives into Therapeutic Approaches
The International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches (SPRINT), includes participants with extensive know-how in basic research, clinical trials, regulatory affairs, and the biomedical industry. SPRINT will join forces to strengthen the knowledge in the field, and overcome the bottlenecks of translation to provide innovative therapeutic applications of Perinatal-derived tissues, cells, and factors.
Due to COVID-19 pandemic, we are currently awaiting the cancellation of travel restrictions and new information will be available soon thereafter.
If you want to be updated about the
activities and results of SPRINT, you can sign up to our info mailing list.
To sign up, simply email us the email address you want to use for the mailing list.